Scientists test pill to turn back the clock on aging
NCT ID NCT07354620
First seen Jan 21, 2026 · Last updated May 14, 2026 · Updated 22 times
Summary
This early-phase study tests whether a drug called rapamycin can reverse biological aging in 52 healthy adults aged 50 to 80. Participants take the drug for six months, and researchers measure changes in a DNA-based 'aging clock' that estimates biological age. The goal is to see if we can slow or reverse the aging process itself, not just treat age-related diseases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AIM for Wellbeing
Cincinnati, Ohio, 45236, United States
Conditions
Explore the condition pages connected to this study.